Organigram Holdings (TSX.V: OGI) (OTCQB: OGRMF) this morning said that is has closed its short form prospectus offering of convertible unsecured debentures of the company on a bought deal basis, including the full exercise of the over-allotment option. A total of 115,000 convertible debentures were sold during the offering at a price of $1,000 each, resulting in gross proceeds of $115,000,000 to the company. Organigram intends to use the proceeds from the offering to support the strengthening of its stance within the Canadian and global cannabis markets. The securities have not been and will not be offered or sold within the United States.
To view the full press release, visit http://cnw.fm/G9zOe
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram’s facility is located in Moncton, New Brunswick and the company is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). Organigram has been ranked in the top ten Clean Technology & Life Sciences Sector on the TSX Venture Exchange 50. For more information, visit the company’s website at www.Organigram.ca.
More from CannabisNewsBreaks
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com